These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 12838185

  • 1. Is there a role for corticosteroids in Kawasaki disease?
    Shulman ST.
    J Pediatr; 2003 Jun; 142(6):601-3. PubMed ID: 12838185
    [No Abstract] [Full Text] [Related]

  • 2. Resistant Kawasaki disease.
    Nachiappan J, May M, Hawker RE, Hong P.
    J Paediatr Child Health; 2004 Jun; 40(9-10):576-8. PubMed ID: 15367156
    [No Abstract] [Full Text] [Related]

  • 3. Treatment of Kawasaki disease.
    Taddio A, Rosé CD.
    N Engl J Med; 2007 Jun 28; 356(26):2747; author reply 2748. PubMed ID: 17600908
    [No Abstract] [Full Text] [Related]

  • 4. Response of refractory Kawasaki disease to intravenous methylprednisolone.
    Shah I, Prabhu SS.
    Ann Trop Paediatr; 2009 Mar 28; 29(1):51-3. PubMed ID: 19222935
    [Abstract] [Full Text] [Related]

  • 5. Adverse effects of methylprednisolone pulse therapy in refractory Kawasaki disease.
    Miura M, Ohki H, Yoshiba S, Ueda H, Sugaya A, Satoh M, Yamagishi H.
    Arch Dis Child; 2005 Oct 28; 90(10):1096-7. PubMed ID: 16177169
    [No Abstract] [Full Text] [Related]

  • 6. Treatment of severe complicated Kawasaki disease with oral prednisolone and aspirin.
    Dale RC, Saleem MA, Daw S, Dillon MJ.
    J Pediatr; 2000 Nov 28; 137(5):723-6. PubMed ID: 11060542
    [Abstract] [Full Text] [Related]

  • 7. The use of corticosteroid therapy in refractory Kawasaki patients.
    Al-Mayouf SM.
    Clin Rheumatol; 2004 Feb 28; 23(1):11-3. PubMed ID: 14749974
    [Abstract] [Full Text] [Related]

  • 8. Severe cutaneous manifestations in a child with refractory Kawasaki disease.
    Falcini F, Ricci L, Poggi GM, Simonini G, Calabri GB, de Martino M.
    Rheumatology (Oxford); 2006 Nov 28; 45(11):1444-5. PubMed ID: 16847007
    [No Abstract] [Full Text] [Related]

  • 9. Revisiting steroids in the primary treatment of acute Kawasaki disease.
    Burns JC.
    J Pediatr; 2006 Sep 28; 149(3):291-2. PubMed ID: 16939734
    [No Abstract] [Full Text] [Related]

  • 10. Effects of steroid pulse therapy on immunoglobulin-resistant Kawasaki disease.
    Furukawa T, Kishiro M, Akimoto K, Nagata S, Shimizu T, Yamashiro Y.
    Arch Dis Child; 2008 Feb 28; 93(2):142-6. PubMed ID: 17962370
    [Abstract] [Full Text] [Related]

  • 11. [Advance in diagnosis and treatment of intravenous immunogolobulin-resistant Kawasaki disease].
    Zhang Q.
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Apr 28; 11(4):318-21. PubMed ID: 19374823
    [No Abstract] [Full Text] [Related]

  • 12. [Reply to questions regarding diagnosis and treatment of Kawasaki disease].
    Wang HW.
    Zhonghua Er Ke Za Zhi; 2006 May 28; 44(5):337-8. PubMed ID: 16780708
    [No Abstract] [Full Text] [Related]

  • 13. Corticosteroids in the initial treatment of Kawasaki disease: report of a randomized trial.
    Sundel RP, Baker AL, Fulton DR, Newburger JW.
    J Pediatr; 2003 Jun 28; 142(6):611-6. PubMed ID: 12838187
    [Abstract] [Full Text] [Related]

  • 14. Guidelines for medical treatment of acute Kawasaki disease: report of the Research Committee of the Japanese Society of Pediatric Cardiology and Cardiac Surgery (2012 revised version).
    Research Committee of the Japanese Society of Pediatric Cardiology, Cardiac Surgery Committee for Development of Guidelines for Medical Treatment of Acute Kawasaki Disease.
    Pediatr Int; 2014 Apr 28; 56(2):135-58. PubMed ID: 24730626
    [No Abstract] [Full Text] [Related]

  • 15. Corticosteroid treatment of refractory Kawasaki disease.
    Lang BA, Yeung RS, Oen KG, Malleson PN, Huber AM, Riley M, Ebbeson R, Ramsey SE, Laxer RM, Silverman ED, McCrindle BW, Ratnapalan S, Feldman BM.
    J Rheumatol; 2006 Apr 28; 33(4):803-9. PubMed ID: 16583481
    [Abstract] [Full Text] [Related]

  • 16. Intravenous immunoglobulin plus corticosteroids prevent coronary artery abnormalities in Kawasaki disease.
    Brogan P, Levin M.
    Evid Based Med; 2013 Dec 28; 18(6):217-8. PubMed ID: 23564929
    [No Abstract] [Full Text] [Related]

  • 17. Methylprednisolone pulse therapy for massive lymphadenopathy in a child with intravenous immunoglobulin-resistant Kawasaki disease.
    Chen HH, Liu PM, Bong CN, Wu YT, Yang KD, Wang CL.
    J Microbiol Immunol Infect; 2005 Apr 28; 38(2):149-52. PubMed ID: 15843862
    [Abstract] [Full Text] [Related]

  • 18. Response of refractory Kawasaki disease to pulse steroid and cyclosporin A therapy.
    Raman V, Kim J, Sharkey A, Chatila T.
    Pediatr Infect Dis J; 2001 Jun 28; 20(6):635-7. PubMed ID: 11419513
    [Abstract] [Full Text] [Related]

  • 19. Treatment of Kawasaki disease: corticosteroids revisited.
    Newburger JW.
    J Pediatr; 1999 Oct 28; 135(4):411-3. PubMed ID: 10518072
    [No Abstract] [Full Text] [Related]

  • 20. Typical Kawasaki disease with atypical pneumonia: a paediatric case report.
    Maggio MC, Cimaz R, Failla MC, Dones P, Corsello G.
    Scand J Rheumatol; 2021 May 28; 50(3):248-249. PubMed ID: 32804000
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.